assembly Bill A7712B

Signed By Governor
2021-2022 Legislative Session

Provides for a myalgic encephalomyelitis/chronic fatigue syndrome education and outreach program

download bill text pdf

Sponsored By

Archive: Last Bill Status - Signed by Governor


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (18)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 30, 2022 signed chap.244
Jun 22, 2022 delivered to governor
May 11, 2022 returned to assembly
passed senate
3rd reading cal.519
substituted for s6928b
May 10, 2022 referred to health
delivered to senate
passed assembly
May 02, 2022 amended on third reading 7712b
Apr 28, 2022 advanced to third reading cal.542
Apr 25, 2022 reported
Jan 05, 2022 referred to ways and means
Jun 09, 2021 reported referred to rules
Jun 02, 2021 print number 7712a
Jun 02, 2021 amend and recommit to ways and means
May 25, 2021 reported referred to ways and means
May 20, 2021 referred to health

Co-Sponsors

A7712 - Details

See Senate Version of this Bill:
S6928
Law Section:
Public Health Law
Laws Affected:
Amd §207, Pub Health L

A7712 - Summary

Provides for a myalgic encephalomyelitis/chronic fatigue syndrome ("ME/CFS") education and outreach program.

A7712 - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   7712
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               May 20, 2021
                                ___________
 
 Introduced  by  M.  of  A.  GOTTFRIED  --  read once and referred to the
   Committee on Health
 
 AN  ACT  to  amend  public  health  law,  in  relation  to  the  myalgic
   encephalomyelitis/chronic  fatigue  syndrome  education  and  outreach
   program
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subdivision  1 of section 207 of the public health law is
 amended by adding a new paragraph (p) to read as follows:
   (P) MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME  ("ME/CFS"),  A
 MULTI-SYSTEM  DISEASE  ASSOCIATED  WITH  NEUROLOGICAL, IMMUNOLOGICAL AND
 ENERGY METABOLISM IMPAIRMENT CHARACTERIZED BY LONG-STANDING AND  DEBILI-
 TATING  FATIGUE  WITH  A  DELAYED  EXACERBATION  OF SYMPTOMS AND LOSS OF
 STAMINA FOLLOWING EVEN MINIMAL MENTAL OR PHYSICAL FUNCTION; SYMPTOMS MAY
 ALSO  INCLUDE  COGNITIVE  DYSFUNCTION,  SLEEP  ABNORMALITIES,  AUTONOMIC
 MANIFESTATIONS  AND  PAIN; SUSCEPTIBILITY MAY BE GENETIC BUT THE DISEASE
 CAN BE TRIGGERED BY INFECTION IN THE MAJORITY OF PATIENTS. ME/CFS  IS  A
 COMMON  CHRONIC  CONSEQUENCE  OF  VIRUSES, WITH TEN TO TWELVE PERCENT OF
 THOSE WITH SERIOUS INFECTION GOING ON TO DEVELOP THE DISEASE. GIVEN THAT
 THERE ARE NO DIAGNOSTIC TESTS OR BIOMARKERS, AND  NO  FEDERAL  FOOD  AND
 DRUG  ADMINISTRATION  APPROVED  TREATMENTS  FOR  ME/CFS,  DIAGNOSIS  AND
 MANAGEMENT OF THIS DISEASE CAN BE MORE DIFFICULT. THERE ARE FEW CLINICAL
 EXPERTS AVAILABLE IN NEW YORK  STATE,  SO  EDUCATION  AND  AWARENESS  OF
 HEALTH  CARE PROVIDERS AND THE PUBLIC IS IMPERATIVE. EDUCATION MATERIALS
 SHALL INCLUDE BUT NOT BE LIMITED TO INFORMATION ABOUT DIAGNOSING  ME/CFS
 INCLUDING  SPECIFIC  SCIENTIFIC  INFORMATION  ABOUT WHAT THE DISEASE IS,
 WHAT THE SYMPTOMS ARE, WHO IS SUSCEPTIBLE AND HOW PATIENTS ARE CURRENTLY
 TREATED. ME/CFS EDUCATION AND AWARENESS  MATERIALS  SHALL  ALSO  INCLUDE
 RECOGNITION  THAT  ME/CFS IS A REAL DISEASE, IS NOT A PSYCHIATRIC DISOR-
 DER, IS NOT CAUSED BY A LACK OF EXERCISE  AND  THAT  MANAGEMENT  OF  THE
 DISEASE CAN BE MORE DIFFICULT AS A RESULT.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law.
 

Co-Sponsors

view additional co-sponsors

A7712A - Details

See Senate Version of this Bill:
S6928
Law Section:
Public Health Law
Laws Affected:
Amd §207, Pub Health L

A7712A - Summary

Provides for a myalgic encephalomyelitis/chronic fatigue syndrome ("ME/CFS") education and outreach program.

A7712A - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  7712--A
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               May 20, 2021
                                ___________
 
 Introduced  by M. of A. GOTTFRIED, BARRON, KELLES, SILLITTI, McDONALD --
   read once and referred to the Committee  on  Health  --  reported  and
   referred  to  the Committee on Ways and Means -- committee discharged,
   bill amended, ordered reprinted as amended  and  recommitted  to  said
   committee

 AN  ACT  to  amend  public  health  law,  in  relation  to  the  myalgic
   encephalomyelitis/chronic  fatigue  syndrome  education  and  outreach
   program
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 1 of section 207 of the public  health  law  is
 amended by adding a new paragraph (p) to read as follows:
   (P)  MYALGIC  ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME ("ME/CFS"), A
 MULTI-SYSTEM DISEASE ASSOCIATED  WITH  NEUROLOGICAL,  IMMUNOLOGICAL  AND
 ENERGY  METABOLISM IMPAIRMENT CHARACTERIZED BY LONG-STANDING AND DEBILI-
 TATING FATIGUE.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law.
 
 
 
 

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD11614-02-1


Co-Sponsors

view additional co-sponsors

A7712B (ACTIVE) - Details

See Senate Version of this Bill:
S6928
Law Section:
Public Health Law
Laws Affected:
Amd §207, Pub Health L

A7712B (ACTIVE) - Summary

Provides for a myalgic encephalomyelitis/chronic fatigue syndrome ("ME/CFS") education and outreach program.

A7712B (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  7712--B
                                                         Cal. No. 542
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                               May 20, 2021
                                ___________
 
 Introduced  by M. of A. GOTTFRIED, KELLES, SILLITTI, McDONALD, BARNWELL,
   L. ROSENTHAL, STERN, PAULIN, McMAHON, GALLAGHER, STIRPE, SIMON, GALLA-
   HAN,  GONZALEZ-ROJAS,  ABINANTI,  BURDICK,  CLARK  --  read  once  and
   referred  to  the  Committee on Health -- reported and referred to the
   Committee on Ways and Means --  committee  discharged,  bill  amended,
   ordered  reprinted  as  amended  and  recommitted to said committee --
   recommitted to the Committee on Ways  and  Means  in  accordance  with
   Assembly  Rule  3,  sec.  2  -- reported from committee, advanced to a
   third reading, amended and ordered reprinted, retaining its  place  on
   the order of third reading
 
 AN  ACT  to  amend  public  health  law,  in  relation  to  the  myalgic
   encephalomyelitis/chronic  fatigue  syndrome  education  and  outreach
   program
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 1 of section 207 of the public  health  law  is
 amended by adding a new paragraph (q) to read as follows:
   (Q)  MYALGIC  ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME ("ME/CFS"), A
 MULTI-SYSTEM DISEASE ASSOCIATED  WITH  NEUROLOGICAL,  IMMUNOLOGICAL  AND
 ENERGY  METABOLISM IMPAIRMENT CHARACTERIZED BY LONG-STANDING AND DEBILI-
 TATING FATIGUE.
   § 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law.
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD11614-05-2